TRVN (Trevena) Days Sales Outstanding : 0.00 (As of Sep. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Trevena Days Sales Outstanding?

Trevena's average Accounts Receivable for the three months ended in Sep. 2024 was $0.00 Mil. Trevena's Revenue for the three months ended in Sep. 2024 was $0.28 Mil. Hence, Trevena's Days Sales Outstanding for the three months ended in Sep. 2024 was 0.00.

The historical rank and industry rank for Trevena's Days Sales Outstanding or its related term are showing as below:

TRVN' s Days Sales Outstanding Range Over the Past 10 Years
Min: 8.44 Med: 27.08 Max: 119.66
Current: 119.66

During the past 13 years, Trevena's highest Days Sales Outstanding was 119.66. The lowest was 8.44. And the median was 27.08.

TRVN's Days Sales Outstanding is ranked worse than
74.05% of 867 companies
in the Biotechnology industry
Industry Median: 70.69 vs TRVN: 119.66

Trevena's Days Sales Outstanding declined from Sep. 2023 (90.74) to Sep. 2024 (0.00).

Trevena Days Sales Outstanding Historical Data

The historical data trend for Trevena's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Trevena Days Sales Outstanding Chart

Trevena Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

8.44

45.71

Trevena Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Days Sales Outstanding	Get a 7-Day Free Trial															90.74	-	-	-	-

Competitive Comparison of Trevena's Days Sales Outstanding

For the Biotechnology subindustry, Trevena's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Trevena's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Trevena's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Trevena's Days Sales Outstanding falls into.

Trevena Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Trevena's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	3.125	*	365
=	0					/	3.125	*	365
=	0.00

Trevena's Days Sales Outstanding for the quarter that ended in Sep. 2024 is calculated as:

	Days Sales Outstanding (Q: Sep. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2024 )	+	Accounts Receivable (A: Sep. 2024 ))	/	count )	/	Revenue (A: Sep. 2024 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0.283	*	365 / 4
=	0					/	0.283	*	365 / 4
=	0.00

Trevena (OTCPK:TRVN) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Trevena Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Trevena's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Trevena Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Trevena Inc (OTCPK:TRVN) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

955 Chesterbrook Boulevard, Suite 110, Chesterbrook, PA, USA, 19087

Website

https://www.trevena.com

Trevena Inc is an American biopharmaceutical company focused on developing and commercializing novel medicines for patients affected by central nervous system, or CNS, disorders.

Executives

Mark Corrigan	director
Mark Demitrack	officer: SVP, Chief Medical Officer	955 CHESTERBROOK BOULEVARD, SUITE 200, CHESTERBROOK PA 19087
Robert T Yoder	officer: SVP, Chief Business Officer	955 CHESTERBROOK BOULEVARD, SUITE 110, SUITE 200, CHESTERBROOK PA 19087
Carrie L. Bourdow	director, officer: President & CEO	C/O TREVENA, INC., 1018 WEST 8TH AVENUE, SUITE A, KING OF PRUSSIA PA 19406
Patricia M. Drake	officer: SVP, Chief Commercial Officer	245 FIRST STREET, SUITE 1800, CAMBRIDGE MA 02142
Barry Shin	officer: SVP, CFO	C/O TREVENA, INC., 955 CHESTERBROOK BLVD, SUITE 110, CHESTERBROOK PA 19087
Marvin Johnson	director	C/O TREVENA, INC., 955 CHESTERBROOK BOULEVARD, STE. 110, CHESTERBROOK PA 19087
Barbara Yanni	director	1018 W. 8TH AVENUE, SUITE A, KING OF PRUSSIA PA 19406
Moulder Leon O Jr	director	C/O TESARO, INC., 1000 WINTER STREET, SUITE 3300, WALTHAM MA 02451
Jason Raleigh Nunn	director	1119 ST. PAUL STREET, BALTIMORE MD 21202
Scott Braunstein	director	C/O ESPERION THERAPEUTICS, INC., 3891 RANCHERO DRIVE, SUITE 150, ANN ARBOR MI 48108
Michael R Dougherty	director	C/O ADOLOR CORP, 700 PENNSYLVANIA DR, EXTON PA 19341
Anne M. Phillips	director	C/O TREVENA, INC., 1018 WEST 8TH AVENUE, KING OF PRUSSIA PA 19406
Scott Applebaum	officer: CLCO; SVP, Regulatory Affairs	C/O TREVENA INC., 955 CHESTERBROOK BOULEVARD, SUITE 110, CHESTERBROOK PA 19087
John P. Hamill	officer: Int. Prin. Fin. Off. and PAO	4092 NEW HOPE ROAD, FURLONG PA 18925